- Issuer ticker
-
XRAY
- Reported as of
-
03 Mar 2025
- Net transaction value
-
-$124,914
Source evidence
Original filing metadata and source links for verification.
5 source fields
- SEC form
-
4
- Accepted by SEC
-
05 Mar 2025, 18:29:20 UTC
Reporting owner
1 detail
- Reporting owner signature
-
/s/ Lindi Barton-Brobst, Attorney-In-Fact for Richard C. Rosenzweig
Key filing fact
Richard C. Rosenzweig filed Form 4 for DENTSPLY SIRONA Inc. (XRAY) on 05 Mar 2025.
Key facts
- This page summarizes Richard C. Rosenzweig's Form 4 filing for DENTSPLY SIRONA Inc. (XRAY).
- 5 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 05 Mar 2025, 18:29.
Change
- Previous filing in this sequence was filed on 14 Jan 2025.
- Current net transaction value: -$124,914.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
Ownership activity is grounded in SEC Form 4 disclosures.
View source filing
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
XRAY
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +33,771
- Change %
- +59%
- Price
-
$0.000000
- Shares after
- 90,671
- Date
- 03 Mar 2025
- Ownership
- Direct
- Footnotes
- F1
XRAY
transaction
Common Stock
Tax liability
- Transaction value
- $23,217
- Shares
- -1,452
- Change %
- -1.6%
- Price
-
$15.99
- Shares after
- 89,219
- Date
- 03 Mar 2025
- Ownership
- Direct
- Footnotes
- F2
XRAY
transaction
Common Stock
Tax liability
- Transaction value
- $79,246
- Shares
- -4,956
- Change %
- -5.6%
- Price
-
$15.99
- Shares after
- 84,263
- Date
- 03 Mar 2025
- Ownership
- Direct
- Footnotes
- F2
XRAY
transaction
Common Stock
Tax liability
- Transaction value
- $22,450
- Shares
- -1,440
- Change %
- -1.7%
- Price
-
$15.59
- Shares after
- 82,823
- Date
- 04 Mar 2025
- Ownership
- Direct
- Footnotes
- F2
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
XRAY
transaction
Derivative
Stock Option (Right to Buy)
Award
- Transaction value
- $0
- Shares
- +350,100
- Change %
- Price
-
$0.000000
- Shares after
- 350,100
- Date
- 03 Mar 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 350,100
- Exercise price
- $15.99
- Footnotes
- F3
* marks a reported price that did not pass the local price check.
Explanation of responses
3 footnotes